Plant Extracts

DBCAT001604Pharmacologic class

Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. A DrugBank category of 65 drugs. 22 of them are approved.

Also known as: Extracts, Plant
Drugs: 20-Hydroxyecdysone
3,4-Dihydroxybenzoic Acid
Acemannan
Alloin
Angelica sinensis root
Anisodamine
Belapectin
Besigomsin
beta-Apopicropodophyllin
Bilberry
Butylphthalide
Calanolide A
Camphor
Centella asiatica
Choline alfoscerate
Cryptotanshinone
Efineptakin alfa
Emodin
Ephedra sinica root
Ephedra sinica stem
Eucommia ulmoides bark
Eupatilin
Forsythia suspensa fruit
Frangula purshiana bark
Ginkgo biloba
and 40 more with a free account

What you can answer from here — as of August 24, 2016

65DrugsEach linked to its full drug card

105Drug targetsEvery drug–target pair in the class, with bond type

2,920Marketed productsAcross the regions we cover, with dosage forms and routes

19Routes of administrationHow the drugs in this class are given

2SubcategoriesNarrower classes within this one

Which targets do Plant Extracts share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account